U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123376) titled 'Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects' on Aug. 08.
Brief Summary: To evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of HRS-9231 injection in a single dose in healthy subjects
Study Start Date: June 05, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: HRS-9231
HRS-9231 was administered intravenously;
DRUG: Placebo
Placebo was administered intravenously.
Recruitment Status: COMPLETED
Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd
Published by HT Digital Content Services with permission from Health ...